Christian Heiss։ When Diabetes and PAD Overlap, Cardiovascular and Limb Risks Rise
Christian Heiss, Associate Head of Medical School (Research and Innovation) at University of Surrey, Professor and NHS Consultant in Interventional Cardiovascular Medicine, shared a post on LinkedIn about a recent article by James Amamoo et al, published in American Journal of Preventive Cardiology:
”New paper worth flagging (Am J Prev Cardiol): in real-world data, people with type 2 diabetes who also have peripheral artery disease (PAD) had markedly higher risks of major adverse cardiovascular events (MACE) and major adverse limb events (MALE) than those without PAD.
It’s also a reminder that PAD remains under-recognised—most diagnostic work-ups still rely on ABI and duplex ultrasound.”
Title: Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes
Authors: James Amamoo, Lin Xie, Andrea Steffens, Erin Buysman, Caroline Swift, Sherif Mehanna, Noelle N. Gronroos, Marc P. Bonaca
Read the Full Article on American Journal of Preventive Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 2, 2026, 16:02Shiny K. Kajal: Platelet Transfusion Is a Therapy – Not a Reflex
-
Feb 2, 2026, 15:37Rana Saifi: An Exciting Time for the Bleeding Disorders Community
-
Feb 2, 2026, 13:08Hammam Alminshawi: Time is Brain – Optimizing MRI for Acute Ischemic Stroke
-
Feb 2, 2026, 12:53Lucie Gelon: Proud to Share My 1st Achievements in The Scientific and Platelet World
-
Feb 2, 2026, 12:32Matthew Flick on SARS-CoV-2 Spike Protein and Coagulation Biology
-
Feb 2, 2026, 11:24Shivanand Kumatagi Delivers an Interactive Session on ISBT128 Standard
-
Feb 2, 2026, 11:03Meghan Delaney Congratulates Ruchika Goel for The Recent Paper on Pediatric Transfusion
-
Feb 2, 2026, 10:31Fayad Al-Haimus: Is Giving TXA Within “3 Hours” Really Enough?
-
Feb 2, 2026, 10:07David Benito Laorga’s Haemophilia Team Hosts Hemosfera